Main Article Content
Acute respiratory distress syndrome (ARDS) is a common acute respiratory failure problem in
critically ill patients, with mortality rates of around 40.0% and causing long-term morbidity in survivors.
ARDS has been defined as Berlin-Definition and may modify in resource-constrained settings. Various
etiologies can induce lung inflammation and leading to the diffuse pulmonary edema that defines ARDS.
The main treatment consists of specific correct lung injury etiology and support in critical illness that must
be undertaken simultaneously. Several supportive strategies: lung-protective ventilation, prone positioning
and neuromuscular blocking agent in order to facilitate mechanical ventilation, show a significant reduction
in mortality. ARDS management in present day, shifting toward prevention and early treatment, is likely
to reduce the incidence and burden of this syndrome